Pesticidal formulations
View Patent ↗The present invention relates to an active composition for controlling or eradicating Phthiraptera, Siphonaptera and Acarina Pests, typically in domestic animals, comprising a synergistic combination of at least one A83543 compound and at least one macrocyclic lactone. The invention also relates to the use of the active composition in pesticidal formulations, the formulations themselves and to the various applications of those formulations as pesticides, specifically in controlling all species of Phthiraptera, Siphonaptera and Acarina pests, typically in domestic animals. Such applications include the control of such external Phthiraptera, Siphonaptera and Acarina pests in domestic animals including but not limited to sheep, cattle, poultry, pigs, goats, camelids, horses, dogs and cats.
1. A systemically active oral composition for controlling fleas in dogs comprising a combination of spinosad, or a salt thereof, and milbemycin oxime in a 10:1 to 100:1 weight/weight ratio, and wherein said flea is Ctenocephalides felis.
2. The composition of claim 1 wherein said spinosad or salt thereof and milbemycin oxime are from 0.1%-40% by weight of the composition.
3. The composition of claim 2 wherein from 60-99.9% by weight of the composition is at least one veterinarily acceptable carrier, diluent, or excipient.
4. The composition of claim 1 wherein said composition is in the form of a tablet, capsule, bolus, solution, suspension, or elixir.
5. The composition of claim 1 wherein said composition comprises spinosad.
6. The composition of claim 3 wherein said composition comprises spinosad.
7. A method of controlling Ctenocephalides felis in a dog comprising administering an effective amount of a systemically active oral composition comprising a combination of spinosad, or a salt thereof, and milbemycin oxime in a 10:1 to 100:1 weight/weight ratio, to said dog.
8. The method of claim 7 wherein said spinosad, or a salt thereof, and milbemycin oxime are from 0.1%-40% by weight of the composition.
9. The method of claim 8 wherein from 60-99.9% by weight of the composition is at least one veterinarily acceptable carrier, diluent, or excipient.
10. The method of claim 7 wherein said composition is in the form of a tablet, capsule, bolus, solution, suspension, or elixir.
11. The method of claim 7 wherein said composition comprises spinosad.
12. The method of claim 9 wherein said composition comprises spinosad.
13. The method of claim 12 wherein said composition is in the form of a tablet, capsule, bolus, solution, suspension, or elixir.
14. The method of claim 13 wherein said composition is in the form of a tablet.